A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
Titel:
A phase II randomised study of preoperative trastuzumab alone or combined with everolimus in patients with early HER2-positive breast cancer and predictive biomarkers (RADHER trial)
Auteur:
Campone, Mario Bachelot, Thomas Treilleux, Isabelle Pistilli, Barbara Salleron, Julia Seegers, Valérie Arnedos, Monica Loussouarn, Delphine Wang, Qing Vanlemmens, Laurence Jimenez, Marta Rios, Maria Diéras, Véronique Leroux, Agnès Paintaud, Gilles Rezai, Keyvan André, Fabrice Lion, Maëva Merlin, Jean-Louis